Degree of microhematuria during follow-up is an independent predictor of eGFR decline after adjusting for clinical and histological parameters. Therefore, monitoring the degree of microhematuria as well as proteinuria is important when evaluating patients with IgAN. Additional studies using improvement in microhematuria as a primary surrogate outcome are needed.
No takes yet. Share an insight, caveat, or question.
Bobart et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: